Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.5 to v3.6.6, indicating a small maintenance update to the page.
    Difference
    0.1%
    Check dated 2026-08-30T16:31:07.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a minor site version update. This reflects an under-the-hood update to the interface rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-08-09T09:17:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page version label has been updated from v3.6.3 to v3.6.4. This reflects a minor update to the page’s rendering or underlying template.
    Difference
    0.1%
    Check dated 2026-07-25T17:51:36.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now shows a new revision stamp (v3.6.3) replacing the previous v3.6.2, indicating a minor deployment update.
    Difference
    0.1%
    Check dated 2026-07-04T04:53:42.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.6.0 to v3.6.2, signaling a new build of the page. The change does not affect the displayed study details or navigation.
    Difference
    0.1%
    Check dated 2026-06-27T02:55:16.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    The listing now displays 'No longer looking for participants', signaling that enrollment has ended; additional help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to guide users.
    Difference
    0.5%
    Check dated 2026-06-12T15:38:55.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.